Prolonged survival of corneal allografts incubated in alloantibody fragments

Transplantation

Volumn 67, Issue 4, 1999, Pages 594-599

  Gebhardt, Bryan M ^a   Varnell, Emily D ^a   Kaufman, Herbert E ^a  

^a LSU EYE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; IMMUNOGLOBULIN F(AB')2 FRAGMENT; IODINE 125;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; CORNEA TRANSPLANTATION; FEMALE; GOAT; GRAFT SURVIVAL; ISOTOPE LABELING; NONHUMAN; PRIORITY JOURNAL; RABBIT; SURVIVAL TIME;

EID: 0033608383     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199902270-00018     Document Type: Article

References (37)

1. Wilson SE, Kaufman HE. Graft failure after penetrating keratoplasty. Surv Ophthalmol 1990; 34: 325.
2. Hill JC, Maske R, Watson P. Corticosteroids in corneal graft rejection: oral versus single pulse therapy. Ophthalmology 1991; 98: 329.
3. Prendergast DGC, Easty DL. Immunological aspects of corneal graft rejection. Immunol Lett 1991; 29: 73.
4. Price FW Jr, Whitson WE, Collins KS, Marks RG. Five-year corneal graft survival: a large, single-center patient cohort. Arch Ophthalmol 1993; 111: 799.
5. Hodkin MJ. Complications of penetrating keratoplasty. In: Kaufman HE, Barron BA, McDonald MB, eds. The cornea. 2nd edition. Boston: Butterworth-Heinemann, 1998: 847.
6. Adorini L, Guery J-C, Trembleau S. Advances in selective immunosuppression. Adv Pharmacol 1995; 33: 255.
7. Chandler JW, Gebhardt BM, Kaufman HE. Immunologic protection of rabbit corneal allografts: preparation and in vitro testing of heterologous "blocking" antibody. Invest Ophthalmol 1973; 12: 646.
8. Binder PS, Gebhardt BM, Chandler JW, Kaufman HE. Immunologic protection of rabbit corneal allografts with heterologous blocking antibody. Am J Ophthalmol 1975; 79: 949.
9. Chandler JW, Gebhardt BM, Sugar J, Kaufman HE. Immunological protection of rabbit corneal allografts. Transplantation 1974; 17: 146.
10. Faustman D, Coe C. Prevention of xenograft rejection by masking donor HLA class I antigens. Science 1991; 252: 1700.
11. Pakzaban P, Deacon TW, Burns LH, Dinsmore J. A novel mode of immunoprotection of neural xenotransplants: masking of donor major histocompatibility complex class I enhances transplant survival in the central nervous system. Neuroscience 1995; 65: 983.
12. 2 antibody fragments directed against donor MHC class-I in a rodent model. Transplant Proc 1996; 28: 817.
13. Gebhardt BM. Immune reactions in the eye. In: Kaufman HE, Zimmerman TJ, eds. Current concepts in ophthalmology. St. Louis: CV Mosby, 1976: 236.
14. Hill JC, Maske R. An animal model for corneal graft rejection in high-risk keratoplasty. Transplantation 1988; 46: 26.
15. Chen YF, Gebhardt BM, Reidy JJ, Kaufman HE. Cyclosporine-containing collagen shields suppress corneal allograft rejection. Am J Ophthalmol 1990; 109: 132.
16. Klyce SD, Beuerman RW. Structure and function of the cornea. In: Kaufman HE, Barron BA, McDonald MB, eds. The cornea. 2nd edition. Boston: Butterworth-Heinemann, 1998: 3.
17. Jones BR. Summing up: present knowledge and problems of corneal graft failure. Symposium on corneal graft failure. Ciba Foundation Symposium. Amsterdam: Elsevier, 1973: 349.
18. Rodrigues MM, Rowden G, Hackett J, Bakos I. Langerhans cells in the normal conjunctiva and peripheral cornea of selected species. Invest Ophthalmol Vis Sci 1981; 21: 759.
19. Gillette TE, Chandler JW, Greiner JV. Langerhans cells of the ocular surface. Ophthalmology 1982; 89: 700.
20. Braude LS, Chandler JW. Corneal allograft rejection. The role of the major histocompatibility complex. Surv Ophthalmol 1983; 27: 290.
21. Maguire MG, Stark WJ, Gottsch JD, Stulting RD, Sugar A, Fink NE, The Collaborative Corneal Transplantation Studies Research Group. Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Ophthalmology 1994; 101: 1536.
22. Boisjoly HM, Bernard P-M, Dubé I, Laughrea P-A, Bazin R, Bernier J. Effect of factors unrelated to tissue matching on corneal transplant endothelial rejection. Am J Ophthalmol 1989; 107: 647.
23. Rapuano CJ, Cohen EJ, Brady SE, Arentsen JJ, Laibson PR. Indications for and outcomes of repeat penetrating keratoplasty. Am J Ophthalmol 1990; 109: 689.
24. Pleyer U, Steuhl KP, Weidle EG, Lisch W, Thiel H-J. Corneal graft rejection: incidence, manifestation, and interaction of clinical subtypes. Transplant Proc 1992; 24: 2034.
25. Belin MW, Bouchard CS, Frantz S, Chmielinska J. Topical cyclosporine in high-risk corneal transplants. Ophthalmology 1989; 96: 2244.
26. Hoffmann F, Pahlitzsch T. Predisposing factors in corneal graft rejection. Cornea 1989; 8: 215.
27. Beekhuis WH. Current clinician's opinions on risk factors in corneal grafting: results of a survey among surgeons in the Eurotransplant area. Cornea 1995; 14: 39.
28. Kaliss N. Immunological enhancement. Int Rev Exp Pathol 1969; 8: 241.
29. Carpenter CB, d'Apice AJF, Abbas AK. The role of antibodies in the rejection and enhancement of organ allografts. Adv Immunol 1976; 22: 1.
30. Batchelor JR. The riddle of kidney graft enhancement. Transplantation 1978; 26: 139.
31. Sugarbaker PH, Chang AE. Enhancing alloantibody effective during sensitization but not effector phase of skin graft rejection. Transplantation 1979; 28: 60.
32. Chang AE, Sugarbaker PH. Abrogation of T cell homing by alloantibody. Transplantation 1980; 29: 127.
33. Collin HB. Endothelial cell lined lymphatics in the vascularized rabbit cornea. Invest Ophthalmol 1966; 5: 337.
34. Chandler JW, Axelrod AJ. Conjunctiva-associated lymphoid tissue: a probable component of the mucosa-associated lymphoid system. In: O'Conner R, ed. Immunologic diseases of the mucosa membrane. New York: Masson Publishing USA, 1980; 63-70.
35. Franklin RM, Remus LE. Conjunctival-associated lymphoid tissue: evidence for a role in the secretory immune system. Invest Ophthalmol Vis Sci 1984; 25: 181.
36. Dua HS, Gomes JAP, Jindal VK, et al. Mucosa specific lymphocytes in the human conjunctiva, corneoscleral limbus and lacrimal gland. Curr Eye Res 1994; 13: 87.
37. Streilein JW, Niederkorn JY. Induction of anterior chamber-associated immune deviation requires an intact, functional spleen. J Exp Med 1981; 153: 1058.